Boyden Expands in Europe by Appointing Six New Partners and One Principal 21-11-2024, 14:05

Bitget Delivers A Knockout Experience: VIP Access to Karate Combat’s KC54 Dubai UFC Fight 26-05-2025, 14:54

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15